CtrlK
PM
NYSE
Tobacco
$181.62
USD
-$5.56 (-2.97%)
At close: Jul 10, 2026, 4:00 PM EDT
Market Cap:
$283.07B
Volume:
4.5M
Previous Close
$187.18
Day Range
$178.45 - $182.52
52 Week Range
$142.11 - $193.05
Average Volume (10 Days)
5.3M
P/E Ratio
24.94
Dividend Yield
3.11%
Philip Morris International, Inc. is a holding company, which engages in the business of delivering a smoke-free future and evolving a portfolio for the long term to include products outside of the tobacco and nicotine sector. The company is headquartered in Stamford, Connecticut and currently employs 84,900 full-time employees. The company went IPO on 2008-03-17. The Company’s product portfolio primarily consists of cigarettes and smoke-free products. Its smoke-free business (SFB) also includes wellness and healthcare products, as well as consumer accessories, such as lighters and matches. The Company’s segments include Europe Region; South and Southeast Asia, Commonwealth of Independent States, Middle East and Africa Region (SSEA, CIS & MEA); East Asia, Australia & PMI Global Travel Retail (EA, AU & PMI GTR), and Americas Region. The firm's brands include Marlboro, HEETS, IQOS, IQOS ILUMA, TEREA, VEEV and ZYN. Its IQOS smoke-free product brand portfolio includes heated tobacco and nicotine-containing vapor products. Its international cigarette brands are Chesterfield, L&M, and Philip Morris. The company also owns a number of local cigarette brands, such as Dji Sam Soe and Sampoerna A in Indonesia, and Fortune and Jackpot in the Philippines.
CEO
Mr. Jacek Olczak
Headquaters
Stamford, CONNECTICUT, US
Founded
2008
Employees
84,900
Philip Morris International is seeing increased mainstream acceptance of its smoke-free product portfolio, particularly Zyn oral nicotine pouches, as regulators and investors warm to alternatives to traditional cigarettes. The FDA recently approved certain Zyn pouches to be marketed as safer than cigarettes and reversed a ban on flavored vape products, while overall youth tobacco use declined. These developments signal a potential shift in how tobacco companies with significant smoke-free portfolios are viewed by investors and consumers.
0
0
Philip Morris International reported first-quarter earnings that exceeded analyst expectations, with revenue rising 9.1% to $10.15 billion. However, U.S. shipments of its popular Zyn nicotine pouches fell nearly 24%, creating uncertainty around its smoke-free product growth in America despite strong international performance.
0
0
Philip Morris International reported first-quarter revenue of $10.15 billion, beating analyst expectations, driven by strong international smoke-free product growth. However, U.S. shipments of its Zyn nicotine pouches fell nearly 24% despite rising consumer demand, creating uncertainty around its domestic growth strategy.
0
0
Philip Morris reported stronger-than-expected first-quarter earnings, driven by international smoke-free product growth. However, U.S. shipments of its popular Zyn nicotine pouches fell sharply despite rising consumer demand, raising questions about supply constraints and competitive positioning.
0
0
